7 desafios da química analítica frente às necessidades da indústria farmacêutica challenges of analytical chemistry in face of the needs of the pharmaceutical industry

8 rapid identification of coumarins from micromelum falcatum by uplc-hrms/ms and targeted isolation of three new derivatives

9 Profiling of the known-unknown Passiflora variant complement by liquid chromatography - Ion mobility - Mass spectrometry.

10 identification of absorbed constituents in the rabbit plasma and cerebrospinal fluid after intranasal administration of asari radix et rhizoma by hs-spme-gc-ms and hplc-apci-it-tof-msn

11 Analysis of Young Shoots of 'Anji Baicha' (Camellia sinensis) at Three Developmental Stages Using Nontargeted LC-MS-Based Metabolomics.

12 Efficiency of ESI and APCI ionization sources in LC-MS/MS systems for analysis of 22 pesticide residues in food matrix.

13 Development of an UPLC-MS/MS method coupled with in-source CID for quantitative analysis of PEG-PLA copolymer and its application to a pharmacokinetic study in rats.

14 Chemical profiling of Centaurea bornmuelleri Hausskn. aerial parts by HPLC-MS/MS and their pharmaceutical effects: From nature to novel perspectives.

15 Identification of phenolic components via LC-MS analysis and biological activities of two Centaurea species: C. drabifolia subsp. drabifolia and C. lycopifolia.

16 Simultaneous determination of phenolic acids and flavonoids in Artemisiae Argyi Folium by HPLC-MS/MS and discovery of antioxidant ingredients based on relevance analysis.

17 UPLC-MS/MS method for the simultaneous determination of imatinib, voriconazole and their metabolites concentrations in rat plasma.

18 A multi-residue method for determination of 36 endocrine disrupting chemicals in human serum with a simple extraction procedure in combination of UPLC-MS/MS analysis

19 Stability-indicating HPLC method development and structural elucidation of novel degradation products in posaconazole injection by LC-TOF/MS, LC-MS/MS and NMR.

20 Consumer safety evaluation of pyraclostrobin residues in strawberry using liquid chromatography tandem mass spectrometry (LC-MS/MS): An Egyptian profile.

21 Highly sensitive HPLC-MS/MS assay for the quantitation of ondansetron in rat plasma and rat brain tissue homogenate following administration of a very low subcutaneous dose

22 Development and validation of an absolute protein assay for the simultaneous quantification of fourteen CYP450s in human microsomes by HPLC-MS/MS-based targeted proteomics

23 A Validated HPLC-MS/MS Assay for 14-O-[(4,6-Diaminopyrimidine-2-yl)thioacetyl] Mutilin in Biological Samples and Its Pharmacokinetic, Distribution and Excretion via Urine and Feces in Rats

24 Development and validation of a HPLC-MS/MS assay for the determination of lutein concentration in human and rat plasma

25 Simultaneous determination of cytosine arabinoside and its metabolite uracil arabinoside in human plasma by LC-MS/MS: Application to pharmacokinetics-pharmacogenetics pilot study in LAM patients.

26 Carry-over assessment of fumonisins and zearalenone to poultry tissues after exposure of chickens to a contaminated diet – A study implementing stable-isotope dilution assay and UHPLC-MS/MS

27 Development and validation of an LC-MS/MS method for the simultaneous determination of bedaquiline and rifabutin in human plasma.

28 Novel zwitterionic HILIC stationary phase for the determination of ethyl glucuronide in human hair by LC-MS/MS.

29 Paper spray mass spectrometry for drug analysis: an alternative to LC-MS/MS in forensic, clinical and drug discovery laboratories for dried blood spot samples

30 Simultaneous determination of multiple components in rat plasma and pharmacokinetic studies at a pharmacodynamic dose of Xian-Ling-Gu-Bao capsule by UPLC-MS/MS.

31 Deep Neural Networks for Classification of LC-MS Spectral Peaks.

32 A new HPLC-MS/MS method for simultaneous determination of Cyclosporine A, Tacrolimus, Sirolimus and Everolimus for routine therapeutic drug monitoring.

33 Analysis of Triphenylmethane Dye Residues and their Leuco-Forms in Frozen Fish by LC-MS/MS, Fish Microbial Quality, and Effect of Immersion in Whole Milk on Dye Removal.

34 Identification and determination of deoxynivalenol (DON) and deepoxy-deoxynivalenol (DOM-1) in pig colostrum and serum using liquid chromatography in combination with high resolution mass spectrometry (LC-MS/MS (HR))

35 LC-MS<sup>n</sup> and HR-MS characterization of secondary metabolites from Hypericum japonicum Thunb. ex Murray from Nepalese Himalayan region and assessment of cytotoxic effect and inhibition of NF-κB and AP-1 transcription factors in vitro

36 LC-MS analysis combined with principal component analysis and soft independent modelling by class analogy for a better detection of changes in N-glycosylation profiles of therapeutic glycoproteins.

37 Assessing the mutagens ethylnitrolic acid and 2-methyl-1,4-dinitro-pyrrole in meat products: Sample preparation and simultaneous analysis by LC-MS/MS.

38 Simultaneous determination of calycosin-7-O-β-D-glucoside, cinnamic acid, paeoniflorin and albiflorin in rat plasma by UHPLC-MS/MS and its application to a pharmacokinetic study of Huangqi Guizhi Wuwu Decoction.

39 Simultaneous determination of six bioactive saponins from Rhizoma Panacis Japonici in rat plasma by UHPLC-MS/MS: Application to a pharmacokinetic study.

40 A UHPLC-MS/MS method for simultaneous determination of twelve constituents from Erigeron breviscapus extract in rat plasma: Application to a pharmacokinetic study.

41 A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.

42 Simultaneous determination of seven alkaloids in rat plasma by UFLC-MS/MS and its application to a pharmacokinetic study after oral administration of Cerebralcare Granule.

43 Simultaneous determination of six bioactive constituents of Guizhi Fuling Capsule in rat plasma by UHPLC-MS/MS: Application to a pharmacokinetic study.

44 Simultaneous determination of ten compounds in rat plasma by UPLC-MS/MS: Application in the pharmacokinetic study of Ma-Zi-Ren-Wan.

45 LC-MS/MS and LC-UV Determination of Moniliformin by Adding Lanthanide Ions to the Mobile Phase.

46 Fast and accurate bacterial species identification in urine specimens using LC-MS/MS mass spectrometry and machine learning.

47 Development and validation of a methodology based on Captiva EMR-lipid clean-up and LC-MS/MS analysis for the simultaneous determination of mycotoxins in human plasma.

48 Farklı Yapıdaki Organik Patlayıcı Maddelerin LC-MS-MS ile Belirlenmesi

49 Development of an analytical method for identification of Aspergillus flavus based on chemical markers using HPLC-MS.

50 Validation of a HILIC UHPLC-MS/MS Method for Amino Acid Profiling in Triticum Species Wheat Flours.

51 Green Analysis: High Throughput Analysis of Emerging Pollutants in Plant Sap by Freeze-Thaw-Centrifugal Membrane Filtration Sample Preparation - HPLC-MS/MS Analysis.

52 Rapid detection and structural characterization of verapamil metabolites in rats by UPLC-MS and UNIFI platform.

53 Validation of an UHPLC-MS/MS Method for the Determination of Glaucocalyxin A, a Novel Potent Negative Akt Regulator in Rat Plasma, Lung and Brain Tissues: Application to a Pharmacokinetic Study.

54 A Sensitive and Quantitative Isotope-Dilution LC-MS/MS Method for Analysis of Hydrazine in Tobacco Smoke.

55 Optimization of sample preparation for transporter protein quantification in tissues by LC-MS/MS.

56 A nanofiber mat prepared from sulfonated polyaniline for solid-phase extraction of fluoroquinolones from water and biological fluids prior to their quantitation by UPLC-MS/MS.

57 Development of an LC-MS/MS-based method for quantitation of osimertinib in human plasma and cerebrospinal fluid.

58 Modern Approaches in the Identification and Quantification of Immunogenic Peptides in Cereals by LC-MS/MS.

59 Electrospun core-shell nanofibers as an adsorbent for on-line micro-solid phase extraction of monohydroxy derivatives of polycyclic aromatic hydrocarbons from human urine, and their quantitation by LC-MS.

60 Determination of total, free and saliva mycophenolic acid with a LC-MS/MS method: application to pharmacokinetic study in healthy volunteers and renal transplant patients.

61 Development and validation of an LC-MS/MS method for the simultaneous determination of bisphenol A and its chlorinated derivatives in adipose tissue.

62 Screening of potential biomarkers for Yin-deficiency-heat syndrome based on UHPLC-MS method and the mechanism of Zhibai Dihuang granule therapeutic effect.

63 Optimization of XCMS parameters for LC-MS metabolomics: an assessment of automated versus manual tuning and its effect on the final results.

64 Assessment of salivary free cortisol levels by liquid chromatography with tandem mass spectrometry (LC-MS/MS) in patients treated with mitotane.

65 Metabolite Profiling by UPLC-MS, NMR, and Antioxidant Properties of Amazonian Fruits: Mamey Apple (Mammea Americana), Camapu (Physalis Angulata), and Uxi (Endopleura Uchi).

66 A feasible UHPLC-MS/MS method for concurrent quantification of 10 bioactive principles in Aquilaria leaf tea by the multiple reaction monitoring analytical mode.

67 Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS

68 Simultaneous Quantification of Ethambutol and Amikacin in Human Sputum by HPLC-MS/MS

69 Development and full validation of a multiresidue method for the analysis of a wide range of pesticides in processed fruit by UHPLC-MS/MS.

70 Pharmacokinetics, Tissue Distribution, and Excretion Study of Cajanonic Acid A in Rats by UPLC-MS/MS.

71 LC-MS/MS for simultaneous detection and quantification of Amadori compounds in tomato products and dry foods and factors affecting the formation and antioxidant activities.

72 New trends in sample preparation: on-line microextraction in packed syringe (MEPS) for LC and GC applications Part III: Determination and validation of local anaesthetics in human plasma samples using a cation-exchange sorbent, and MEPS-LC-MS-MS.

73 Development of a sensitive and rapid UHPLC-MS/MS method for simultaneous quantification of nine compounds in rat plasma and application in a comparative pharmacokinetic study after oral administration of Xuefu Zhuyu Decoction and nimodipine.

74 integrated lc-ms/ms system for plant metabolomics

75 label-free lc-ms profiling of skeletal muscle reveals heart-type fatty acid binding protein as a candidate biomarker of aerobic capacity

76 studies on the formation and forming mechanism of the related substance e in potassium clavulanate production by hplc-ms/ms

77 determination of raloxifene hydrochloride in human urine by lc-ms-ms

78 validation of a lc-ms/ms method for quantifying urinary nicotine, six nicotine metabolites and the minor tobacco alkaloids--anatabine and anabasine--in smokers' urine.

79 identification of the chemical constituents in simiao wan and rat plasma after oral administration by gc-ms and lc-ms

80 Structural elucidation of amino amide-type local anesthetic drugs and their main metabolites in urine by LC-MS after derivatization and its application for differentiation between positional isomers of prilocaine

81 New forced degradation products of vildagliptin: Identification and structural elucidation using LC-MS, with proposed formation mechanisms

82 a lc-ms-based method for quantification of biomarkers from serum of allergic rats

83 chemical and physical methods to analyze a multicomponent traditional chinese herbal prescription using lc-ms/ms, electron microscope, and congo red staining

84 simultaneous analysis of major ingredients of gardenia fruit by hplc-ms/tqms method

85 simultaneous determination of pioglitazone and candesartan in human plasma by lc-ms/ms and its application to a human pharmacokinetic study

86 development of an efficient protein extraction method compatible with lc-ms/ms for proteome mapping in two australian seagrasses zostera muelleri and posidonia australis

87 influence of pretreatment of piperazine ferulate on pharmacokinetic parameters of methotrexate in methotrexate-induced renal injury model rats by hplc-ms

88 a selective detection of lysophosphatidylcholine in dried blood spots for diagnosis of adrenoleukodystrophy by lc-ms/ms

89 quantification of serotonin o-sulphate by lc-ms method in plasma of healthy volunteers.

90 Development and Validation of a UPLC-MS/MS and UPLC-HR-MS Method for the Determination of Fumonisin B1 and Its Hydrolysed Metabolites and Fumonisin B2 in Broiler Chicken Plasma

91 Maximizing Analytical Performance in Biomolecular Discovery with LC-MS: Focus on Psychiatric Disorders.

92 Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method.

93 LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring.

94 A fast and validated LC-MS/MS method to quantify lenvatinib in dried blood spot.

95 UPLC-MS/MS-Based Target Screening of 90 Phosphodiesterase Type 5 Inhibitors in 5 Dietary Supplements

96 LC-MS-Based Metabolomics for the Chemosystematics of Kenyan Jacq (Sapindaceae) Populations.

97 Cost-effective magnetic Nylon 6 composites for extraction of perfluorinated compounds in water and bottled beverage followed with LC-MS/MS analysis.

Keyword Connections

Journals

Research Groups

Bibliographies